Stepwise Enzymatic-Dependent Mechanism of Ebola Virus Binding to Cell Surface Receptors Monitored by AFM.

DC-SIGNR Ebola virus TIM-1 atomic force microscopy attachment cell surface receptor single-virus force spectroscopy

Journal

Nano letters
ISSN: 1530-6992
Titre abrégé: Nano Lett
Pays: United States
ID NLM: 101088070

Informations de publication

Date de publication:
23 02 2022
Historique:
pubmed: 3 2 2022
medline: 11 3 2022
entrez: 2 2 2022
Statut: ppublish

Résumé

Ebola virus (EBOV) is responsible for several outbreaks of hemorrhagic fever with high mortality, raising great public concern. Several cell surface receptors have been identified to mediate EBOV binding and internalization, including phosphatidylserine (PS) receptors (TIM-1) and C-type lectin receptors (DC-SIGNR). However, the role of TIM-1 during early cell surface binding remains elusive and in particular whether TIM-1 acts as a specific receptor for EBOV. Here, we used force-distance curve-based atomic force microscopy (FD-based AFM) to quantify the binding between TIM-1/DC-SIGNR and EBOV glycoprotein (GP) and observed that both receptors specifically bind to GP with high-affinity. Since TIM-1 can also directly interact with PS at the single-molecule level, we also confirmed that TIM-1 acts as dual-function receptors of EBOV. These results highlight the direct involvement of multiple high-affinity receptors in the first steps of binding to cell surfaces, thus offering new perspectives for the development of anti-EBOV therapeutic molecules.

Identifiants

pubmed: 35108019
doi: 10.1021/acs.nanolett.1c04677
doi:

Substances chimiques

Lectins, C-Type 0
Receptors, Cell Surface 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1641-1648

Auteurs

Qingrong Zhang (Q)

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve 1348, Belgium.

Jinsung Yang (J)

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve 1348, Belgium.

Sueli Tillieux (S)

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve 1348, Belgium.

Zhengyuan Guo (Z)

State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.

Rita Dos Santos Natividade (RDS)

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve 1348, Belgium.

Melanie Koehler (M)

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve 1348, Belgium.

Simon Petitjean (S)

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve 1348, Belgium.

Zongqiang Cui (Z)

State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.

David Alsteens (D)

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve 1348, Belgium.
Walloon Excellence in Life sciences and Biotechnology (WELBIO), Wavre 1300, Belgium.

Articles similaires

Humans Hemorrhagic Fever, Ebola Democratic Republic of the Congo Survivors Disease Outbreaks

HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression.

Aiat Shaban Hemida, Mohamed Mohamady Ahmed, Mona Saeed Tantawy
1.00
Humans Carcinoma, Pancreatic Ductal Pancreatic Neoplasms Antigens, CD Antigens, Differentiation, Myelomonocytic
Humans Apoptosis Mitochondria Cell Line, Tumor Proto-Oncogene Proteins c-bcl-2

Classifications MeSH